SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-011821
Filing Date
2021-08-16
Accepted
2021-08-16 16:31:29
Documents
59
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q tmb-20210630x10q.htm   iXBRL 10-Q 1971485
2 EX-10.6 tmb-20210630xex10d6.htm EX-10.6 299520
3 EX-10.7 tmb-20210630xex10d7.htm EX-10.7 381862
4 EX-10.8 tmb-20210630xex10d8.htm EX-10.8 396158
5 EX-31.1 tmb-20210630xex31d1.htm EX-31.1 16516
6 EX-31.2 tmb-20210630xex31d2.htm EX-31.2 13533
7 EX-32.1 tmb-20210630xex32d1.htm EX-32.1 7662
8 EX-32.2 tmb-20210630xex32d2.htm EX-32.2 7040
  Complete submission text file 0001558370-21-011821.txt   7436399

Data Files

Seq Description Document Type Size
9 EX-101.SCH tmb-20210630.xsd EX-101.SCH 39808
10 EX-101.CAL tmb-20210630_cal.xml EX-101.CAL 35071
11 EX-101.DEF tmb-20210630_def.xml EX-101.DEF 195862
12 EX-101.LAB tmb-20210630_lab.xml EX-101.LAB 281151
13 EX-101.PRE tmb-20210630_pre.xml EX-101.PRE 301463
14 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20210630x10q_htm.xml XML 994404
Mailing Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014 7816524507
MUSTANG BIO, INC. (Filer) CIK: 0001680048 (see all company filings)

IRS No.: 473828760 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38191 | Film No.: 211178884
SIC: 2834 Pharmaceutical Preparations